| Name | MAT2A-IN-3 |
|---|---|
| Synonyms | Pyrido[4,3-d]pyrimidin-7(6H)-one, 8-[4-(difluoromethoxy)phenyl]-6-(2-methyl-2H-indazol-5-yl)-2-(2,2,2-trifluoroethoxy) |
| Description | MAT2A-IN-3 is a potent inhibitor of MAT2A. The expression level of MAT2A is abnormally high in several types of tumors, including gastric, colon, liver and pancreatic cancers. MAT2A-IN-3 reduces the proliferative activity of MTAP-deficient cancer cells. MAT2A-IN-3 has the potential for the research of cancer diseases (extracted from patent WO2019191470A1, compound 265)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C24H16F5N5O3 |
|---|---|
| Molecular Weight | 517.41 |